Literature DB >> 901734

Plasma, bone, hip capsule, synovial and drain fluid concentrations of lincomycin during total hip replacement.

R L Parsons, J P Beavis, G A Hossack, G M Paddock.   

Abstract

1 Lincomycin (600 mg) was given 6 h preoperatively by intramuscular injection, as an intravenous infusion over 30 min and for 72 h postoperatively in twelve patients having total hip replacement. 2 The plasma, bone, hip capsule, synovial and drain fluid concentrations of lincomycin were almost always above the M.I.C. of lincomycin against penicillinase producing Staphylococcus aureus. 3 There was a good correlation between the estimated concentrations of lincomycin in bone by the grinding and agitation methods of analysis. 4 Two patients developed pseudomembranous colitis after parenteral lincomycin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901734      PMCID: PMC1429047          DOI: 10.1111/j.1365-2125.1977.tb00758.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Lincomycin bone concentrations during total hip replacement [proceedings].

Authors:  J P Beavis; G M Hossack; R L Parsons; G M Paddock
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Antibiotics in bone.

Authors:  R L Parsons
Journal:  J Antimicrob Chemother       Date:  1976-09       Impact factor: 5.790

3.  Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.

Authors:  R F McGehee; C B Smith; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1968-11       Impact factor: 2.378

4.  Total hip replacement in inflammatory hip disease using the Charnley prosthesis.

Authors:  J Harris; C D Lightowler; R C Todd
Journal:  Br Med J       Date:  1972-06-24

5.  Total hip replacement in osteoarthrosis using the Charnley prosthesis.

Authors:  R C Todd; C D Lightowler; J Harris
Journal:  Br Med J       Date:  1972-06-24

6.  Postoperative infection in total prosthetic replacement arthroplasty of the hip-joint. With special reference to the bacterial content of the air of the operating room.

Authors:  J Charnley; N Eftekhar
Journal:  Br J Surg       Date:  1969-09       Impact factor: 6.939

7.  Penetration of lincomycin ('Lincocin') and clindamycin ('Dalacin C') into the synovial cavity in rheumatoid arthritis.

Authors:  S D Deodhar; F Russell; W C Dick; G Nuki; W W Buchanan
Journal:  Curr Med Res Opin       Date:  1972       Impact factor: 2.580

8.  Pseudomembranous colitis. Association with antibiotics and therapy with cholestyramine.

Authors:  E J Burbige; F D Milligan
Journal:  JAMA       Date:  1975-03-17       Impact factor: 56.272

9.  Infection following total hip replacement in a general hospital without special orthopaedic facilities.

Authors:  M K Benson; S P Hughes
Journal:  Acta Orthop Scand       Date:  1975-12

10.  In-vitro comparison of erythromycin, lincomycin, and clindamycin.

Authors:  L Phillips; R Fernandes; C Warren
Journal:  Br Med J       Date:  1970-04-11
View more
  2 in total

1.  Plasma concentration/time curve of erythromycin after a 12-hour intravenous infusion of erythromycin lactobionate in man.

Authors:  R L Parsons; J David; G M Paddock; S T Stamp
Journal:  Postgrad Med J       Date:  1978-02       Impact factor: 2.401

2.  Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen.

Authors:  R L Parsons; J P Beavis; M Laurence; J A David; G M Paddock; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.